Hello and welcome to this week's edition of Circulation on the Run. My name is Dr. Pishoy Gouda from the University of Alberta, and I'm joined today with Dr. Alexander Fanaroff from the University of ...
He had a history of atrial fibrillation (AF) that initially occurred 2 years before in the context of streptococcal ...
View all available purchase options and get full access to this article.
View all available purchase options and get full access to this article.
View all available purchase options and get full access to this article.
Mitochondrial dysfunction is a key factor in the development of atherogenesis. METTL4 (methyltransferase-like protein 4) mediates N6- methyldeoxyadenosine (6mA) of mammalian mitochondrial DNA (mtDNA).
Our understanding of hypertension and the ability to lower blood pressure (BP) with pharmacotherapy advanced immensely during the second half of the 20th century and the early 21st century. However, ...
From Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville Campus, Victoria, Australia (R.H.R.) Division of Endocrinology and Metabolism (E.D.A.), ...
Our vision is to innovate and incorporate promising technologies to communicate freely available, high-priority, high-quality content, which accelerates scientific progress and advances heart and ...
The following brief summary seems justified from the large volume of accumulated data dealing with the reaction of the cardiovascular system in the anemic patient. There are four mechanisms operating ...
Request permissions for this article.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback